The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Carcinoma, Non-Small-Cell Lung

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinoma, Non-Small-Cell Lung


High impact information on Carcinoma, Non-Small-Cell Lung


Chemical compound and disease context of Carcinoma, Non-Small-Cell Lung


Biological context of Carcinoma, Non-Small-Cell Lung


Anatomical context of Carcinoma, Non-Small-Cell Lung


Gene context of Carcinoma, Non-Small-Cell Lung


Analytical, diagnostic and therapeutic context of Carcinoma, Non-Small-Cell Lung


  1. Taxol: a novel investigational antimicrotubule agent. Rowinsky, E.K., Cazenave, L.A., Donehower, R.C. J. Natl. Cancer Inst. (1990) [Pubmed]
  2. Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer. Yi, C., McCarty, J.H., Troutman, S.A., Eckman, M.S., Bronson, R.T., Kissil, J.L. Mol. Cell. Biol. (2005) [Pubmed]
  3. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate. Kantor, J., Irvine, K., Abrams, S., Snoy, P., Olsen, R., Greiner, J., Kaufman, H., Eggensperger, D., Schlom, J. Cancer Res. (1992) [Pubmed]
  4. Lung cancer presenting with solitary bone metastases. Case 2: acrometastasis as an initial presentation of non-small-cell lung carcinoma. Jänne, P.A., Datta, M.W., Johnson, B.E. J. Clin. Oncol. (1999) [Pubmed]
  5. Modern treatment of lung cancer: case 2. Response to erlotinib after failure of gefitinib in a patient with advanced non-small-cell lung carcinoma. Garfield, D.H. J. Clin. Oncol. (2005) [Pubmed]
  6. Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells. Knick, V.C., Eberwein, D.J., Miller, C.G. J. Natl. Cancer Inst. (1995) [Pubmed]
  7. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. Kantor, J., Irvine, K., Abrams, S., Kaufman, H., DiPietro, J., Schlom, J. J. Natl. Cancer Inst. (1992) [Pubmed]
  8. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Maxwell, S.A., Davis, G.E. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  9. Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. Lin, S., Wang, W., Wilson, G.M., Yang, X., Brewer, G., Holbrook, N.J., Gorospe, M. Mol. Cell. Biol. (2000) [Pubmed]
  10. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells. Mukhopadhyay, P., Ali, M.A., Nandi, A., Carreon, P., Choy, H., Saha, D. Cancer Res. (2006) [Pubmed]
  11. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Sun, S.Y., Yue, P., Dawson, M.I., Shroot, B., Michel, S., Lamph, W.W., Heyman, R.A., Teng, M., Chandraratna, R.A., Shudo, K., Hong, W.K., Lotan, R. Cancer Res. (1997) [Pubmed]
  12. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Honore, S., Kamath, K., Braguer, D., Horwitz, S.B., Wilson, L., Briand, C., Jordan, M.A. Cancer Res. (2004) [Pubmed]
  13. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma. Strassheim, D., Shafer, S.H., Phelps, S.H., Williams, C.L. Cancer Res. (2000) [Pubmed]
  14. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines. Levitt, M.L., Gazdar, A.F., Oie, H.K., Schuller, H., Thacher, S.M. Cancer Res. (1990) [Pubmed]
  15. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. Liu, C., Tsao, M.S. Am. J. Pathol. (1993) [Pubmed]
  16. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Ishida, T., Kaneko, S., Akazawa, K., Tateishi, M., Sugio, K., Sugimachi, K. Cancer Res. (1993) [Pubmed]
  17. Cigarette smoking is a determinant of DT-diaphorase gene expression in human non-small cell lung carcinoma. Gasdaska, P.Y., Powis, G., Hyman, P., Fisher, H. Cancer Res. (1993) [Pubmed]
  18. Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Catzavelos, C., Tsao, M.S., DeBoer, G., Bhattacharya, N., Shepherd, F.A., Slingerland, J.M. Cancer Res. (1999) [Pubmed]
  19. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han, S., Khuri, F.R., Roman, J. Cancer Res. (2006) [Pubmed]
  20. BRAF and RAS mutations in human lung cancer and melanoma. Brose, M.S., Volpe, P., Feldman, M., Kumar, M., Rishi, I., Gerrero, R., Einhorn, E., Herlyn, M., Minna, J., Nicholson, A., Roth, J.A., Albelda, S.M., Davies, H., Cox, C., Brignell, G., Stephens, P., Futreal, P.A., Wooster, R., Stratton, M.R., Weber, B.L. Cancer Res. (2002) [Pubmed]
  21. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł. Malkinson, A.M., Siegel, D., Forrest, G.L., Gazdar, A.F., Oie, H.K., Chan, D.C., Bunn, P.A., Mabry, M., Dykes, D.J., Harrison, S.D. Cancer Res. (1992) [Pubmed]
  22. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Hashimoto, T., Kobayashi, Y., Ishikawa, Y., Tsuchiya, S., Okumura, S., Nakagawa, K., Tokuchi, Y., Hayashi, M., Nishida, K., Hayashi, S., Hayashi, J., Tsuchiya, E. Cancer Res. (2000) [Pubmed]
  23. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Hibi, K., Westra, W.H., Borges, M., Goodman, S., Sidransky, D., Jen, J. Am. J. Pathol. (1999) [Pubmed]
  24. Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells. Katabi, M.M., Chan, H.L., Karp, S.E., Batist, G. Hum. Gene Ther. (1999) [Pubmed]
  25. Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Liu, C., Woo, A., Tsao, M.S. Br. J. Cancer (1990) [Pubmed]
  26. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Koukourakis, M.I., Giatromanolaki, A., Thorpe, P.E., Brekken, R.A., Sivridis, E., Kakolyris, S., Georgoulias, V., Gatter, K.C., Harris, A.L. Cancer Res. (2000) [Pubmed]
  27. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. Hirsch, F.R., Varella-Garcia, M., Bunn, P.A., Di Maria, M.V., Veve, R., Bremmes, R.M., Barón, A.E., Zeng, C., Franklin, W.A. J. Clin. Oncol. (2003) [Pubmed]
  28. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Hirata, T., Fukuse, T., Naiki, H., Hitomi, S., Wada, H. Cancer Res. (1998) [Pubmed]
  29. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. Bremnes, R.M., Veve, R., Gabrielson, E., Hirsch, F.R., Baron, A., Bemis, L., Gemmill, R.M., Drabkin, H.A., Franklin, W.A. J. Clin. Oncol. (2002) [Pubmed]
  30. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. Burke, L., Khan, M.A., Freedman, A.N., Gemma, A., Rusin, M., Guinee, D.G., Bennett, W.P., Caporaso, N.E., Fleming, M.V., Travis, W.D., Colby, T.V., Trastek, V., Pairolero, P.C., Tazelaar, H.D., Midthun, D.E., Liotta, L.A., Harris, C.C. Cancer Res. (1998) [Pubmed]
  31. Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer. Bendik, I., Schraml, P., Ludwig, C.U. Cancer Res. (1998) [Pubmed]
  32. Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies. Williams, J.I., Weitman, S., Gonzalez, C.M., Jundt, C.H., Marty, J., Stringer, S.D., Holroyd, K.J., Mclane, M.P., Chen, Q., Zasloff, M., Von Hoff, D.D. Clin. Cancer Res. (2001) [Pubmed]
  33. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Miyoshi, T., Kondo, K., Hino, N., Uyama, T., Monden, Y. Clin. Cancer Res. (1997) [Pubmed]
  34. In situ detection of Epstein-Barr virus in non-small cell lung carcinomas. Wong, M.P., Chung, L.P., Yuen, S.T., Leung, S.Y., Chan, S.Y., Wang, E., Fu, K.H. J. Pathol. (1995) [Pubmed]
  35. Smoking-related increase of O6-methylguanine-DNA methyltransferase expression in human lung carcinomas. Mattern, J., Koomägi, R., Volm, M. Carcinogenesis (1998) [Pubmed]
WikiGenes - Universities